Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Screening
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Screening
Incidence of CIN2/CIN3+ lesions (which includes invasive cancers and in situ adenocarcinomas) found by subsequent screening (i.e. after the enrollment screening round and its associated follow-up).
On average 4 years post baseline
Joakim Dillner, MD
Malmo University Hospital, Lund University
Sweden: Regional Ethical Review Board